While our results suggest that SLC26A4-mediated HCO3– secretion would be beneficial for CF airways, other studies have implicated this transporter in fluid absorption, as shown in airway cells from patients with Pendred Syndrome, where the SLC26A4 gene is mutated, but CFTR is still active. This evidence concerns the gene SLC26A4 and Pendred syndrome.